Teva Pharmaceutical Industries Ltd
Close on Nov 17, 2026Market cap $49.66BP/E 71.0Yield –
Teva Pharmaceutical Industries Cash Used for Capital Investments by Quarter
Cash Used for Capital Investments (Per FCF Table) ($M)
Teva Pharmaceutical Industries Cash Used for Capital Investments: -$120M in Q3 2026, down 11.8% from a year earlier.
Where the Q3 2026 figure comes from
“|| Capital investment | (120) | (136)”
Source: Form 8-K Earnings Release (0001171843-26-007054) ↗
Reported in SEC Form 10-K / Form 10-Q / Form 8-K Earnings Releases.
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Teva Pharmaceutical Industries Cash Used for Capital Investments ($M), quarterly Q1 2018–Q3 2026 [Data set]. Compiled from Teva Pharmaceutical Industries SEC filings and investor materials. https://stockdatahq.com/stocks/teva/kpis/fcf-capex
See every metric in the Teva Pharmaceutical Industries KPI table. Data updated Nov 10, 2026.
See a number that looks wrong?